Day 1: Friday, 6th July 2018
Venue: Level 1, Theatrette, Tan Tock Seng Hospital
| TIME | TOPIC | SPEAKERS | |
|---|---|---|---|
| 0800 – 0830 | Registration | ||
| 0830 – 0840 | Opening Ceremony | ||
| 0830 – 0840 | Welcome Address by Course Director | ||
| 0840 – 0900 | Endoscopy Lecture I | Chairperson: | ANG Tiing Leong |
| 0840 – 0900 | Endocytoscopy – A Primer | Yuichi MORI | |
| 0900 – 1010 | Live Endoscopy Demonstrations Session I | ||
| Moderators: | ANG Tiing Leong | ||
| Constantinos ANASTASSIADES | |||
| Dadang MAKMUN | |||
| 1010 – 1030 | Morning Tea Break and Viewing of Exhibits | ||
| 1030 – 1050 | Endoscopy Lecture II | Chairperson: | Christopher KHOR |
| 1030 – 1050 | Complications of Therapeutic Endoscopy | Simon LO | |
| 1050 – 1200 | Live Endoscopy Demonstrations Session II | ||
| Moderators: | Christopher KHOR | ||
| QUAN Wai Leong | |||
| 1200 – 1330 | Lunch and Viewing of Exhibits | ||
| 1215 – 1245 | Lunch Symposium – Sponsored by Fujifilm Screening Endoscopy Using LCI and BLI – Advanced Diagnostic Method for Upper GI Cancers by Color Image |
Hiroyuki OSAWA | |
| 1245 – 1330 | Lunch (continuation) and Viewing of Exhibitions | ||
| 1330 – 1440 | Live Endoscopy Demonstrations Session III | Chairperson: | LIM Li Lin |
| Moderators: | Christopher KONG | ||
| LIM Li Lin | |||
| YAP Chin Kong | |||
| 1440 – 1500 | Afternoon Tea Break and Viewing of Exhibits | ||
| 1500 – 1520 | Endoscopy Lecture III | Chairperson: | YIM Heng Boon |
| 1500 – 1520 | An Update on EUS Guided Tissue Acquisition | Anand SAHAI | |
| 1520 – 1630 | Live Endoscopy Demonstrations Session IV | ||
| Moderators: | Kenneth KOO | ||
| ONG Wai Choung | |||
| YIM Heng Boon | |||
| 1630 – 1710 | Video Case Presentations | Chairperson/Judge: | YAP Chin Kong |
| Judges: | Anad SAHAI | ||
| Noriya UEDO | |||
| 1630 – 1638 | Endoscopic Treatment of Anal Neoplasia | ||
| 1640 – 1648 | Anti-Reflux Mucosectomy (ARMS) | ||
| 1650 – 1658 | Insulated-Tip (IT) knife – Alternative Method in Marsupializing a Duodenal Duplication Cyst | ||
| 1700 – 1708 | Choledochoduodenostomy and Duodenal Stenting | ||
| 1710 – 1718 | Over-The-Scope Clip: How and When to Use | ||
| 1720 – 1730 | Closing | ||
| 1720 – 1730 | Closing Remarks by Course Director | ||
| END OF ENDOSCOPY WORKSHOP | |||
| 1930 – 2130 | Faculty Dinner (All Faculty) |
| MODERATORS | MODERATORS | LOCAL FACULTY |
|---|---|---|
| ANG Tiing Leong, CGH | LIM Li Lin, NUH | Andrew KWEK, CGH |
| Christopher KHOR, SGH | ONG Wai Choung, SGH | Bhavesh DOSHI, NUH |
| Christopher KONG, SKH | QUAN Wai Leong, RS | Damien TAN, SGH |
| Constantinos ANASTASSIADES, KTPH | YAP Chin Kong, MEH | Stephen TSAO, TTSH |
| Dadang MAKMUN, Indonesia | YIM Heng Boon, MEH | CHUA Tju Siang, MEH |
| Kenneth KOO, NTFGH |
Day 2: Saturday, 7th July 2018
Level 6, Mandarin Grand Ballroom 2, Mandarin Orchard
| TIME | TOPIC | SPEAKERS | |
|---|---|---|---|
| 0830 – 0845 | Registration | ||
| 0845 – 0945 | Free Paper Oral Presentations | Chairperson: | WANG Yu Tien |
| LOW How Cheng | |||
| Judges: | Kentaro SUGANO | ||
| Ray KIM | |||
| Roland CHONG | |||
| 0845 – 0855 | Association Between Human Gut Microbiota and the Host Central Obesity | ||
| 0855 – 0905 | Customising Polyethyleneimine (PEI) Polymer for Hepatitis B Virus Therapy in Cellular and Animal Models | ||
| 0905 – 0915 | Use of Vibration Controlled Transient Elastography (Fibroscan) With or Without Platelet Count to Predict Presence of Large Oesophageal Varices | ||
| 0915 – 0925 | Development and International Validation of a Survival Prediction Score for All Patients with Hepatocellular Carcinoma (HCC) at the Time of HCC Diagnosis Regardless of Therapy Eventually Received | ||
| 0925 – 0935 | Direct Antiviral Agent as First-Line Therapy for Genotype 3 Hepatitis C Virus in Singapore: Estimating the Optimal Cost Based on Real-World Experience | ||
| 0935 – 0945 | Decoding Hepatitis B Viral Genome Mutations to Solve the Mystery of HBeAg-Negative Reactivation | ||
| 0945 – 1100 | Morning Tea Break and Viewing of Exhibits | ||
| 1000 – 1040 | Poster Round | Judges: | Arjuna DE SILVA |
| GWEE Kok Ann | |||
| TAN Seok Siam | |||
| 1000 – 1005 | A Retrospective Study of Budd Chiari Syndrome (BCS) Patients In A Singapore Hospital | ||
| 1005 – 1010 | Characteristics of Extra-Intestinal Manifestations (EIM) In A Local Cohort of Patients with Inflammatory Bowel Disease (IBD) | ||
| 1010 – 1015 | Clinical Manifestations, Treatment and Prognosis of Wilson’s Disease – Outcomes from A Tertiary Hospital in Singapore | ||
| 1015 – 1020 | Pilot Feasibility Analysis of Mindfulness Based Cognitive Therapy (MBCT) For Functional Dyspepsia in A Tertiary Referral Centre in Singapore | ||
| 1020 – 1025 | Safety of Calcineurin Inhibitor Monotherapy Conversion in Liver Transplant Recipients | ||
| 1025 – 1030 | Screening and Brief Intervention in Primary Care Setting in Singapore: A Missed Opportunity? | ||
| 1030 – 1035 | The “ASSURANCE” IBD Neoplasia Surveillance Software Guides Patient Management and Data Collection: Results from Asia-Pacific. | ||
| 1035 – 1040 | Vedolizumab Has Similar Incidence of Clostridium Difficile Infection in Comparison to Anti-TNF Therapies- A Retrospective Cohort Study | ||
| 1100 – 1230 | HCC Symposium | Chairperson: | Ivy YAP |
| Varocha MAHACHAI | |||
| 1100 – 1120 | Impact of Anti-viral Treatment on HCC Development | Ray KIM | |
| 1120 – 1140 | Advances in Locoregional Therapy for HCC | TAN Poh Seng | |
| 1140 – 1200 | Immunotherapy and Chemotherapy for HCC | CHOO Su Pin | |
| 1200 – 1220 | Surgery and Transplantation for HCC | IYER Shridhar Ganpathi | |
| 1220 – 1230 | Question and Answer Session | ||
| 1230 – 1340 | Lunch | ||
| 1245 – 1315 | Lunch Symposium (Sponsored by DCH Auriga Singapore) |
||
| Evolution of Infliximab Biosimilar: CT-P13 | Stefan SCHREIBER | ||
Key Clinical Evidence of CT-P13: From Concept to Clinical Practice
|
Stefan SCHREIBER | ||
| 1315 – 1340 | Lunch (continuation) and Viewing of Posters and Exhibits | ||
| 1340 – 1400 | Opening | Chairperson: | CHUA Tju Siang |
| 1340 – 1345 | Welcome Address by Scientific Chair, GESS | WANG Yu Tien | |
| 1345 – 1350 | Welcome Address by Chairman, Nursing Chapter, GESS | LEE Chuey Shan | |
| 1350 – 1400 | Opening Address by President, GESS | LING Khoon Lin | |
| 1400 – 1500 | Plenary Session | Chairperson: | LOW How Cheng |
| Jose SOLLANO | |||
| 1400 – 1430 | Seah Cheng Siang Memorial Oration – Gastroenterology in Singapore – Evolving Challenges | YANG Wei Lyn | |
| 1430 – 1500 | Plenary Lecture – The Evolving Treatment Algorithms and Treatment Targets for IBD in the Next Decade | Stephen HANAUER | |
| 1500 – 1520 | Afternoon Tea Break and Viewing of Posters and Exhibits | ||
| 1520 – 1700 | IBD Symposium | Chairperson: | LIM Wee Chian |
| Nwe NI | |||
| 1520 – 1600 | New Drugs for IBD: How do We Fit Them into Our Treatment Algorithm | ||
| 1520 – 1540 New Mesalazines and Steroids in the Treatment of Mild – Moderate UC | Ida HILMI | ||
| 1540 – 1600 New Biologic Agents for Moderate – Severe IBD | OOI Choon Jin | ||
| 1600 – 1620 | The Role of the IBD Nurse in Patients on Biologic Therapy | Joan HEATHRINGTON | |
| 1620 – 1700 | Debate: EARLY Surgery or Isolated Ileocecal Disease Crohn’s Disease | Proposition: | Yves PANIS |
| Opposition: | Stephen HANAUER | ||
| 1700 – 1800 | GESS AGM (For GESS Members ONLY) | ||
| 1730 – 1830 | Pre-conference Dinner Cocktail | ||
| 1830 – 2100 | GIHep Evening Symposium and Conference Dinner | ||
| 1830 – 1900 | Evening Lecture | Chairperson: | A/Prof Chow Wan Cheng |
| Looking Ahead: Treating Chronic Hepatitis B Virus Infection in 2020 | Ray KIM | ||
| 1900 – 1915 | Prize and Award Presentation | Emcee: | David ONG |
| Award Presentation – Medical Category | Award Presenter: | NG Pock Liok | |
| Award Presentation – Nursing Category | Award Presenter: | LEE Chuey Shan | |
| 1915 – 2100 | Conference Dinner | ||
| END OF DAY 1 ANNUAL SCIENTIFIC MEETING |
Day 3: Saturday, 8th July 2018
Venue: Level 6, Mandarin Grand Ballroom 2, Mandarin Orchard
| TIME | TOPIC | SPEAKERS | |
|---|---|---|---|
| 0800 – 0830 | Registration | ||
| 0830 – 1000 | Liver Symposium – Practical Approach to Hepatology Referrals | Chairperson: | LUI Hock Foong |
| Murdani ABDULLAH | |||
| 0830 – 0850 | “Please See for ? Hepatorenal Syndrome – My Patient Has Abnormal LFT and Renal Impairment” | YANG Wei Lyn | |
| 0850 – 0910 | “Please See for ? Hepatic Encephalopathy – My Drowsy Patient Has Raised Serum Ammonia” | CHOW Wan Cheng | |
| 0910 – 0930 | “Should I Observe or Treat My 40 Years Old Patient with Chronic Hepatitis B, Normal LFT, Normal Fibrosis Test and Elevated HBV DNA” | TAN Seok Siam | |
| 0930 – 0940 | Presence of Steatosis Does Not Increase the Risk of HCC in Patients with Chronic Hepatitis B Over Long Follow-up | LIM Chong Teik | |
| 0940 – 0950 | Effect of Mobile Technology on Lifestyle Intervention and Weight Loss in Patients with Non-alcoholic Fatty Liver Disease: A Randomised Controlled Trial | LOO Wai Mun | |
| 0950 – 1000 | Question and Answer Session | ||
| 1000 – 1030 | Morning Tea Break and Viewing of Posters and Exhibits | ||
| 1030 – 1200 | Upper GI Symposium | Chairperson: | Kenneth KOO |
| Than Than AYE | |||
| 1030 – 1050 | Pathophysiology and Prevention of NSAID-enteropathy: Focus on Gut Microbiota | Carmelo SCARPIGNATO | |
| 1050 – 1110 | Preventing Gastric Cancer through H. Pylori Eradication | Kentaro SUGANO | |
| 1110 – 1130 | Treatment of Refractory GERD | FOCK Kwong Ming | |
| 1130 – 1150 | Management of Anticoagulants During Endoscopy | Lawrence HO | |
| 1150 – 1200 | Question and Answer Session | ||
| 1200 – 1315 | Lunch | ||
| 1215 – 1245 | Lunch Symposium (Sponsored by Takeda Pharmaceuticals (Asia Pacific)) Treatment of Helicobacter Pylori in 2018 |
Kentaro SUGANO | |
| 1245 – 1315 | Lunch (continuation) and Viewing of Posters and Exhibitions | ||
| 1315 – 1445 | Gastroenterology and the Gut Microbiome | Chairperson: | Arjuna DE SILVA |
| David ONG | |||
| 1315 – 1335 | Probiotics for GI Diseases | GWEE Kok Ann | |
| 1335 – 1355 | Microbiota-directed Therapies in Digestive Diseases | Carmelo SCARPIGNATO | |
| 1355 – 1415 | Genetic Modification of Probiotic | HO Chun Loong | |
| 1415 – 1425 | Serum Biomarkers for Detection of Gastric Cancer in a Singapore Chinese Population | Joy CHUA | |
| 1425 – 1445 | Question and Answer Session | ||
| 1445 – 1515 | Afternoon Tea Break and Viewing of Posters and Exhibits | ||
| 1515 – 1645 | Endoscopy Potpourri | Chairperson: | Thein MYINT |
| Eric WEE | |||
| 1515 – 1535 | POEM – The Singapore Experience | Jimmy SO | |
| 1535 – 1555 | Role of EUS in Portal Hypertension | Anand SAHAI | |
| 1555 – 1615 | Artificial Intelligence (AI)-Assisted Colonoscopy | Yuichi MORI | |
| 1615 – 1635 | Strategies to Diagnose and Manage Complications of OGD and Colonoscopy | Simon LO | |
| 1635 – 1645 | Question and Answer Session | ||
| 1645 – 1700 | Closing | ||
| 1645 – 1700 | Closing Remarks by President | CHUA Tju Siang | |
| END OF MEETING | |||
Day 2: Saturday, 7th July 2018
Venue: Level 5, Grange Ballroom, Mandarin Orchard
| TIME | TOPIC | SPEAKERS | |
|---|---|---|---|
| 1245 – 1300 | Registration | ||
| 1300 – 1400 | Lunch Symposium – Sponsored by Pfizer Pte Ltd | Chairperson: | GWEE Kok Ann |
| 1300 – 1345 | Safe NSAIDs Use for Chronic Pain – Looking at GI and Beyond | Carmelo SCARPIGNATO | |
| 1345 – 1400 | Lunch (continuation) and Viewing of Posters and Exhibitions (Level 6 Mandarin Grand Ballroom 3) |
||
| 1400 – 1500 | Luminal Symposium | Chairperson: | Christopher CHIA |
| 1400 – 1420 | Helicobactor Pylori – Is it Still a Problem? | Kentaro SUGANO | |
| 1420 – 1440 | Update in the Management of Stubborn Constipation | Kewin SIAH | |
| 1440 – 1500 | Probiotic | GWEE Kok Ann | |
| 1500 – 1530 | Afternoon Tea Break and Viewing of Posters and Exhibits (Level 6, Mandarin Grand Ballroom 3) |
||
| 1530 – 1630 | Liver Symposium | Chairperson: | CHIA Chung King |
| 1530 – 1550 | Supplements and Drug Induced Liver Injury | TAN Poh Seng | |
| 1550 – 1610 | Fatty Liver – Is it Only Down to Diet and Exercise? | YEW Kuo Chao | |
| 1610 – 1630 | Doctor, is My Liver Ok? How to Assess Liver Function Accurately | LU Wei | |
| End of GP Symposium |
Disclaimer: Whilst every attempt will be made to ensure that all aspects of the programme will take place as scheduled, the Organisers reserve the right to make appropriate changes should the need arise.